IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#133
Positioning
Market Dominance
Manufacturing
Tobacco Products
$89.2B
Jack Marie Henry David Bowles
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. The company offers its products under the Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Camel, Newport, Natural American Spirit, being Vapour, THP, and Modern Oral brands.
Headcount
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = BTI ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$BTI British American Tobacco p.l.c. | 69 | 72 | 89 | 61 | - | 4.5x | 26.5% | 10.7% | 82.8% | 10.6% | 12.3% | -6.8% | 0.0% | 81.0x | $89.2B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
British American Tobacco p.l.c. (BTI) receives a "Buy" rating with a composite score of 68.7/100. It ranks #133 out of 7,333 stocks in our coverage universe and carries a 4-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Jack Marie Henry David Bowles
Chief Executive Officer
Labor Force
52,000
72
38
97
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for BTI
52.0K
HQ Base
LONDON,
Outperforming peers — winners tend to keep winning over 3-12 months
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Top-rated overall — multiple factors aligned for strong entry
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for BTI.
View All RatingsConservative accounting — High cash conversion efficiency
Material decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 72 | 79 | -7DRAG |
| MOMENTUM | 61 | 56 | +5NEUTRAL |
| VALUATION | 89 | 92 | -3NEUTRAL |
| INVESTMENT | 38 | 68 | -30DRAG |
| STABILITY | 97 | 99 | -2NEUTRAL |
| SHORT INT | 63 | 73 | -10DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 6.4% vs WACC 7.8% (spread -1.3%)
GM 83% vs sector 43%, OM 11% vs sector 1%
Capital turnover 0.78x
Rev growth -7%, 8yr history
Interest coverage 2.5x, Net debt/EBITDA 4.3x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
British American Tobacco p.l.c. receives a Buy rating with a composite score of 68.7/100 and 4 out of 5 stars, ranking #133 of 7,333 stocks in our universe. BTI displays a favorable combination of factors that positions it above the majority of the market. While not without risk, the quantitative profile supports a constructive outlook.
BTI earns a quality score of 72/100, indicating above-average business quality. The company reports a return on equity of 26.5% (sector avg: -2.5%), gross margins of 82.8% (sector avg: 42.5%), net margins of 12.3% (sector avg: -0.2%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
BTI carries a solid value score of 89/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include an EV/EBITDA of 4.55x, a P/B ratio of 2.24x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
British American Tobacco p.l.c.'s investment score of 38/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -6.8% vs. a sector average of 5.9% and a return on assets of 10.7% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
BTI demonstrates moderate momentum with a score of 61/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at -6.8% year-over-year, while a beta of 0.11 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
British American Tobacco p.l.c. earns an excellent stability score of 97/100, reflecting low price volatility and a conservatively managed balance sheet. Key stability metrics include a beta of 0.11 and a debt-to-equity ratio of 81.00x (sector avg: 0.2x). Stocks with this level of stability tend to act as portfolio anchors, providing downside protection during market corrections while still participating in broad market advances.
BTI carries a short interest score of 63/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 81.00x). At $89.2B market cap (large-cap), British American Tobacco p.l.c. offers reasonable institutional liquidity.
British American Tobacco p.l.c. is a large-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #133 of 7,333 overall (98th percentile). Key comparisons include ROE of 26.5% exceeding the -2.5% sector median and operating margins of 10.6% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
Quant Factor Profile
Key factor gap
Stability (97) vs Investment (38) — closing this gap could shift the rating.
EV/EBITDA 60% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 1170% BELOW SECTOR MEDIAN
Gross Margin 95% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF DEC 31, 2024 (Q3 FY2024)
We rate British American Tobacco p.l.c. (BTI) as a Buy with a composite score of 68.7/100 at a current price of $61.94. The stock scores above average across the majority of our six quantitative factors and ranks #133 out of 7,333 stocks in our universe, reflecting a favorable risk-reward profile.
The rating is primarily driven by strength in stability (97th percentile) and value (89th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (38th percentile) and momentum (61th percentile) tempers our overall conviction. We assign a No Moat rating (33/100), Low uncertainty, and Standard capital allocation.
Key items to watch: whether strong momentum is fundamentally supported by revenue trends. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
British American Tobacco p.l.c. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 68.7/100 places it at rank #133 in our full 7,333-stock universe. With a $89.2B market capitalization, British American Tobacco p.l.c. operates at meaningful scale within the Manufacturing sector, providing competitive advantages in distribution, procurement, and customer reach.
Despite positive momentum (61th percentile), revenue contraction of -7% creates a divergence between price action and fundamental trajectory. This divergence suggests either that the market is looking through near-term weakness or that technical factors are temporarily inflating the stock. Investors should assess whether the revenue decline reflects cyclical weakness or structural challenges.
The margin cascade tells an important story: gross margins of 83% (+40.3pp vs sector) narrow to operating margins of 11% (+9.3pp vs sector) and net margins of 12.3%, yielding a gross-to-net conversion rate of 15%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $61.94, British American Tobacco p.l.c. appears undervalued relative to its fundamentals. Our value factor score of 89/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at EV/EBITDA of 4.5x (discounted to peers), P/B of 2.2x, P/S of 1.0x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
The stock's Buy rating (composite score 68.7/100) reflects broad-based quantitative strength, placing it in the top 20% of our 7,333-stock universe.
Gross margins of 83% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Returns on equity of 26.5% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
A value factor score of 89/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Return on assets of 10.7% indicates efficient deployment of the full asset base, not just equity capital.
Revenue decline of -7% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
We assign a Low uncertainty rating to British American Tobacco p.l.c.. The company exhibits strong financial stability with a beta of 0.11, and a stability factor in the 97th percentile. The predictable nature of the business model and solid financial position reduce the range of potential outcomes, giving us confidence in our fair value estimate.
Specific risk factors that inform our assessment include: low beta of 0.11 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 97th percentile and quality factor at the 72th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 83% provide a buffer against cost pressures; above-average stability (97th percentile) suggests predictable business dynamics; large-cap scale ($89.2B) provides resilience. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate British American Tobacco p.l.c.'s capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 26.5%, and the balance sheet is managed within acceptable parameters (D/E: 81%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; British American Tobacco p.l.c. falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. Absent a dividend, the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, British American Tobacco p.l.c. receives a Buy rating with a composite score of 68.7/100 (rank #133 of 7,333). Our quantitative framework assigns a No Moat (33/100, trend: stable), Low uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 71/100.
Our analysis supports a constructive view on British American Tobacco p.l.c.. The combination of the current valuation, low uncertainty, and standard capital allocation creates a risk-reward profile that favors accumulation at current levels. We recommend investors consider adding this name to portfolios aligned with the stock's risk profile.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign British American Tobacco p.l.c. a meaningful economic moat, scoring 33/100 on our composite assessment. The ROIC-WACC spread of -1.3% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 17.7/20.
The strongest moat sources are margin superiority (17.7/20) and financial resilience (5.6/20). GM 83% vs sector 43%, OM 11% vs sector 1%. Interest coverage 2.5x, Net debt/EBITDA 4.3x. These pillars form the core of British American Tobacco p.l.c.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (1.1/20) and economic value creation (3.8/20). Capital turnover 0.78x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect British American Tobacco p.l.c.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 83% providing a solid profitability foundation, operating margins of 11% reflecting effective cost management, declining revenues (-7%) that pressure the earnings outlook. The margin cascade from 83% gross to 11% operating to 12.3% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 72th percentile.
The margin profile shows gross margins of 83%, operating margins of 11%, net margins of 12.3%. Return metrics include ROE of 26.5% and ROA of 10.7%. Relative to the Manufacturing sector, gross margins are 40.3 percentage points above the sector median of 43%, and ROE of 26.5% compares to a sector median of -2.5%.
The balance sheet reflects above-average leverage with D/E of 81%, revenue growth of -7%. The sector median D/E is 0%, putting British American Tobacco p.l.c. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
Key Takeaways; Cannabis Sector Organigram Secured C$65.2 Million Strategic Investment from British American Tobacco After the Company Agreed to Acquire Sanity Group Canopy Growth Secured Shareholder Backing for MTL Cannabis Acquisition Green Thumb Expanded Credit Facility with Additional $50 Million Key Takeaways; Psychedelic Sector Enveric Reported New EB‑003 Data Highlighting Non-Hallucinogenic Neuroplastogen Strategy Compass Pathways […]

Organigram Global announced a proposed acquisition of Sanity Group, a German cannabis company, for €113.4 million upfront plus up to €113.8 million in earnout consideration. The deal aims to establish Organigram as a global cannabis pure-play with significant European market presence. Funding will come from cash on hand, a new credit facility, and a €47.8 million investment from British American Tobacco. OGI shares rose 7.09% in premarket trading, though technical indicators show bearish short-to-medium term trends.

Philip Morris International is positioning itself for significant growth in the smoke-free nicotine market, with potential FDA approval for Iqos Iluma in the US and strong performance in alternative nicotine products like Zyn.

Altria maintains a high 7.3% dividend yield despite declining cigarette sales, with financial stability in the short term but potential long-term challenges in transitioning to smoke-free nicotine products.